NeoGenomics
253 hedge funds and large institutions have $995M invested in NeoGenomics in 2026 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 82 reducing their positions, and 40 closing their positions.
906% more call options, than puts
Call options by funds: $6.5M | Put options by funds: $646K
2.28% more ownership
Funds ownership: 101.07% → 103.35% (+2.3%)
5% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 40
4% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 82
1% less funds holding
Funds holding: 256 → 253 (-3)
35% less capital invested
Capital invested by funds: $1.54B → $995M (-$545M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$64.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$18M |
| 3 |
SC
Samlyn Capital
New York
|
+$12.3M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$10.4M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$7.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$31.4M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$26.1M |
| 3 |
D.E. Shaw & Co
New York
|
-$11.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$8.93M |
NEO Hedge Fund Activity: Q1 2026 in Review
253 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2026, worth a combined $995M — down 35% from $1.54B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NEO positions and 40 closed out — a net gain of 2 holders — while 79 added to existing stakes and 82 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $64.8M. The largest seller was Millennium Management, cutting an estimated $31.4M.
- 253 institutional investors held NeoGenomics (NEO) as of Q1 2026, down from 256 in Q4 2025.
- Funds reported $995M of NeoGenomics stock for Q1 2026, down 35% quarter-over-quarter.
- 42 funds opened new NeoGenomics positions in Q1 2026 and 40 closed out, a net change of +2 holders.
- The largest NeoGenomics buyer in Q1 2026 was First Trust Advisors, an estimated $64.8M added.
- The largest NeoGenomics seller in Q1 2026 was Millennium Management, an estimated $31.4M sold.
Based on aggregated 13F filings for Q1 2026.